Iodide

Iodide

SCHEMBL3771125

C[N+](C)(C)CCC[N+](C)(C)C.[I-].[I-]

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 4/20 0.69
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
APEX1 P27695 3/20 0.69
NFKB1 P19838 2/20 0.69
KDM4E B2RXH2 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69
PMP22 Q01453 2/20 0.69
LMNA P02545 2/20 0.69
HSD17B10 Q99714 1/20 0.69
HRH3 Q9Y5N1 1/20 0.69
TSHR P16473 1/20 0.69
RAB9A P51151 1/20 0.69
NPSR1 Q6W5P4 1/20 0.64
DNM1 Q05193 6/20 0.59
BBOX1 O75936 1/20 0.47
APAF1 O14727 1/20 0.47
HSP90AA1 P07900 1/20 0.47
RAD52 P43351 1/20 0.47
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL237389 0.95 MEN1 (0.75) MEN1KMT2AACHEAPEX1NFKB1
Hydrochloric Acid SCHEMBL4541161 0.91 APEX1 (0.77) MEN1KMT2AACHEAPEX1NFKB1
Iodide SCHEMBL1985775 0.91 MEN1 (0.83) MEN1KMT2AACHEAPEX1NFKB1
Decamethonium SCHEMBL2127335 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
Decamethonium SCHEMBL2125690 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
Hexamethonium SCHEMBL7717613 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
Decamethonium SCHEMBL2128894 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
Decamethonium SCHEMBL2126026 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
Pentamethonium SCHEMBL1981108 0.87 MEN1 (0.92) MEN1KMT2AACHEAPEX1NFKB1
SCHEMBL236981 0.86 MEN1 (0.91) MEN1KMT2AACHEAPEX1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851505-B2 Thiotungstate analogues and uses thereof ATTENUON, LLC (US) 2010-12-14 US disclosed
US-20060160805-A1 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation ATTENUON, LLC 2006-07-20 US disclosed
WO-2004110364-A9 THIOTUNGSTATE ANALOGUES AND USES THEREOF ATTENUON L L C (US) 2005-04-07 WO disclosed
US-3932189-A Thermodevelopable photographic material containing high silver ion conducting substance FUJI PHOTO FILM CO., LTD. (JA) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160805-A1 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation NFKBIA, RELA, IKBKG ACHE 2466/4885MEN1 4188/4885KMT2A 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.